OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
May 24, 2022
A new initiative aims to speed the approval of and access to new drugs for young patients around the world, while limiting the number of children needed for testing in clinical trials.
May 11, 2022
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
April 13, 2022
With high-concentration biologics, careful selection of excipients in formulation is crucial for reducing viscosity without destabilizing the protein.
April 08, 2022
NIH has announced four new grant awards to fund new tuberculosis research advancement centers.
April 02, 2022
The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.
March 15, 2022
CAR-T cell therapy development is a complex process that requires standardization.
March 11, 2022
SCG Cell Therapy has signed a collaboration agreement with A*STAR’s BTI to advance the development of antibodies for infectious diseases and cancer treatments.
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
March 09, 2022
A rise in investments and funding into regenerative medicines projects has helped to advance a rich clinical pipeline.